Home > Resources > Videos > Marcela Villarreal on Symposium on Agricultural Biotechnologies

Marcela Villarreal on Symposium on Agricultural Biotechnologies

The Symposium on Agricultural Biotechnologies hosted by FAO is a neutral platform for a scientific debate, an opportunity for governments, researchers, civil society and private sector to debate and exchange ideas. Marcela Villarreal, Director of FAO's Office for Partnerships, Advocacy and Capacity Development, talks about the criterion for choosing participants and who will attend.

Spotlight

PCI Biotech Holding ASA

PCI Biotech is a publicly listed Norwegian biotechnology company with a unique technology to improve localised treatment of cancer. The company has a focused and competent organisation localised at Lysaker just outside Oslo, Norway, with extensive collaboration with international experts and service providers. Clinical development of the lead product started in 2009 and has so far shown very promising results in localised treatment of head & neck cancer. The company has started a Phase II study in head & neck cancer, and is preparing for a phase I/II study in bile duct cancer to start by end of 1H 2013.

OTHER VIDEOS

Image analysis software for true ultra high content data on the MACSima™ Imaging System

video | July 28, 2023

Qi Tissue Image Analysis Software for the MACSima™ Imaging Platform is the key to unlocking staggering analytical ability with ultra high content imaging data generated on the revolutionary new MACSima Imaging Platform....

Watch Now

Bioprinting Living Cells: The Next Frontier in Biotechnology Technology

video | July 30, 2023

Bioprinting with living human cells is transforming healthcare as we know it. From Slurpee-like substances to molding 3D tissues, explore the cutting-edge world of 3D bioprinting. Dr. Mark Skylar-Scott from Stanford University discusses the fascinating realm of 3D bioprinting, a groundbreaking approach that goes beyond traditional plastic printing....

Watch Now

VIA Thaw™ automated dry thawer

video | May 9, 2023

VIA Thaw™ dry automated thawers give you the confidence to reliably recover cryopreserved cellular products. VIA Thaw™ L1000 intended for research or manufacturing use only is an automated dry thawer that you can use for controlled, consistent thawing of cellular products in cryobags....

Watch Now

NeatCell C-Pro application software for the Sepax™ C-Pro instrument

video | May 9, 2023

Meet the NeatCell C-Pro application. It automates the mononuclear cell fraction enrichment from diverse cellular products, and is designed for use with a density-gradient medium like Ficoll-Paque media with the Sepax C-Pro instrument and CT-90.1 single-use kit....

Watch Now

Image analysis software for true ultra high content data on the MACSima™ Imaging System

video | July 28, 2023

Qi Tissue Image Analysis Software for the MACSima™ Imaging Platform is the key to unlocking staggering analytical ability with ultra high content imaging data generated on the revolutionary new MACSima Imaging Platform....

Watch Now

Bioprinting Living Cells: The Next Frontier in Biotechnology Technology

video | July 30, 2023

Bioprinting with living human cells is transforming healthcare as we know it. From Slurpee-like substances to molding 3D tissues, explore the cutting-edge world of 3D bioprinting. Dr. Mark Skylar-Scott from Stanford University discusses the fascinating realm of 3D bioprinting, a groundbreaking approach that goes beyond traditional plastic printing....

Watch Now

VIA Thaw™ automated dry thawer

video | May 9, 2023

VIA Thaw™ dry automated thawers give you the confidence to reliably recover cryopreserved cellular products. VIA Thaw™ L1000 intended for research or manufacturing use only is an automated dry thawer that you can use for controlled, consistent thawing of cellular products in cryobags....

Watch Now

NeatCell C-Pro application software for the Sepax™ C-Pro instrument

video | May 9, 2023

Meet the NeatCell C-Pro application. It automates the mononuclear cell fraction enrichment from diverse cellular products, and is designed for use with a density-gradient medium like Ficoll-Paque media with the Sepax C-Pro instrument and CT-90.1 single-use kit....

Watch Now
MORE VIDEOS

Spotlight

PCI Biotech Holding ASA

PCI Biotech is a publicly listed Norwegian biotechnology company with a unique technology to improve localised treatment of cancer. The company has a focused and competent organisation localised at Lysaker just outside Oslo, Norway, with extensive collaboration with international experts and service providers. Clinical development of the lead product started in 2009 and has so far shown very promising results in localised treatment of head & neck cancer. The company has started a Phase II study in head & neck cancer, and is preparing for a phase I/II study in bile duct cancer to start by end of 1H 2013.

Events